Press Releases Adverum Biotechnologies, Inc.

Equities

ADVM

US00773U2078

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-22 pm EDT			5-day change	1st Jan Change
7.9 ^USD	+0.51%		-9.71%	+4.94%

May. 16	Transcript : Adverum Biotechnologies, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 03:40 PM
May. 09	Adverum Biotechnologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Diabetic Retinopathy Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)	May. 15	AQ
Adverum Biotechnologies: Q1 Earnings Snapshot	May. 09	AQ
Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights	May. 09	AQ
Adverum Biotechnologies to Participate in Upcoming May Investor Conferences	May. 06	AQ
Adverum Biotechnologies to Participate in Upcoming May Investor Conferences	May. 03	AQ
Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting	Apr. 25	AQ
Adverum Biotechnologies: Q4 Earnings Snapshot	Mar. 18	AQ
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates	Mar. 18	AQ
Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care Conference	Feb. 28	AQ
Adverum Biotechnologies to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference	Feb. 12	AQ
Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMD	Feb. 08	AQ
Adverum Biotechnologies Announces $127.5 Million Private Placement Financing	Feb. 05	AQ
Adverum Biotechnologies will Host Webcast to Review LUNA Phase 2 Preliminary Efficacy and Safety Results on February 8, 2024	Feb. 01	AQ
Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific Officer	Jan. 29	AQ
Adverum Biotechnologies to Present LUNA Preliminary Efficacy and Safety Data at the 47th Annual Meeting of the Macula Society	Dec. 07	AQ
Adverum Biotechnologies to Participate in the Evercore ISI 6th Annual HealthCONx Conference	Nov. 28	AQ
Adverum Biotechnologies: Q3 Earnings Snapshot	Nov. 09	AQ
Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights	Nov. 09	AQ
Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023	Nov. 06	AQ
Adverum Biotechnologies Appoints C. David Nicholson, Ph.D. to its Board of Directors	Nov. 06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Adverum Biotechnologies, Inc.

Equities

ADVM

US00773U2078

Press Releases

Filters